CTSH Q3 2025 Earnings
Reported Oct 29, 2025 at 6:32 AM ET · SEC Source
Q3 25 EPS
$1.39
BEAT +6.73%
Est. $1.30
Q3 25 Revenue
$5.42B
BEAT +1.83%
Est. $5.32B
vs S&P Since Q3 25
-48.4%
TRAILING MARKET
CTSH -41.8% vs S&P +6.7%
Market Reaction
Did CTSH Beat Earnings? Q3 2025 Results
Cognizant delivered a convincing third quarter, with adjusted diluted EPS of $1.39 beating the $1.30 consensus estimate by 6.73% and revenue of $5.42 billion clearing expectations by 1.83% on 7.4% year-over-year growth, as the company marked its fift… Read more Cognizant delivered a convincing third quarter, with adjusted diluted EPS of $1.39 beating the $1.30 consensus estimate by 6.73% and revenue of $5.42 billion clearing expectations by 1.83% on 7.4% year-over-year growth, as the company marked its fifth consecutive quarter of organic revenue expansion. The quarter's standout driver was broad-based demand momentum, anchored by the Belcan acquisition contributing roughly 250 basis points to growth and six large deals signed with total contract values exceeding $100 million each, bringing year-to-date TCV growth to 40%. GAAP results were clouded by a $390 million non-cash tax charge tied to the One Big Beautiful Bill Act's repeal of R&E cost capitalization requirements, pulling GAAP diluted EPS to $0.56 from $1.17 a year ago, though adjusted figures reflected genuine underlying progress. The strong performance prompted management to raise full-year 2025 constant currency revenue growth guidance to 6.0%-6.3%, with full-year adjusted EPS now expected in the $5.22-$5.26 range, a signal of growing confidence in the company's AI-driven digital transformation pipeline at a time when peers are similarly lifting their outlooks.
Key Takeaways
- • Fifth consecutive quarter of year-over-year organic revenue growth
- • Strongest sequential organic growth since 2022
- • North America drove geographic outperformance with 7.8% growth
- • Broad-based growth across all segments and geographies
- • Belcan acquisition contributed approximately 250 basis points to YoY revenue growth
- • Six large deals signed in Q3 (TCV $100M+), bringing YTD total to 16 with 40% TCV growth
- • Strong cost discipline drove 70 basis points of YoY Adjusted Operating Margin expansion
- • Trailing 12-month bookings of $27.5 billion, up 5% YoY with 1.3x book-to-bill
CTSH YoY Financials
Q3 2025 vs Q3 2024, source: SEC Filings
CTSH Revenue by Segment
With YoY comparisons, source: SEC Filings
CTSH Revenue by Geography
With YoY comparisons, source: SEC Filings
“Third quarter revenue grew 6.5% year-over-year and 2.8% sequentially in constant currency, representing our fifth consecutive quarter of year-over-year organic revenue growth and our strongest sequential organic growth since 2022.”
— Ravi Kumar S, Q3 2025 Earnings Press Release
CTSH Earnings Trends
CTSH vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
CTSH EPS Trend
Earnings per share: estimate vs actual
CTSH Revenue Trend
Quarterly revenue: estimate vs actual
CTSH Quarterly Results
4 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $1.33 | $1.40 | +4.99% | $5.41B | +0.01% |
| Q4 25 BEAT FY | $1.32 | $1.35 | +2.02% | $5.33B | +0.41% |
| FY Full Year | — | $5.28 | — | $21.11B | — |
| Q3 25 BEAT | $1.30 | $1.39 | +6.73% | $5.42B | +1.83% |
| Q2 25 BEAT | $1.26 | $1.31 | +3.99% | $5.25B | +1.07% |